Alliance for Cancer Gene Therapy (ACGT) awarded The Edward Netter Leadership Award to Crystal Mackall, MD, of Stanford University.
Alliance for Cancer Gene Therapy (ACGT) awarded The Edward Netter Leadership Award to Crystal Mackall, MD, of Stanford University, at the ACGT Awards Luncheon on March 30 at Riverpark restaurant at the Alexandria Center for Life Science in New York City.
The ACGT Awards Luncheon celebrated the non-profit organization’s 20th anniversary and ushered in a new decade. The event was held during the intermission of the ACGT Summit 2023.
Attendees, including scientists and donors, helped ACGT recognize Dr. Mackall for her incredible achievements, such as the numerous groundbreaking clinical trials she has led to treat children with sarcomas and brain cancers. Named for ACGT co-founder, Edward Netter, the award recognizes a researcher who has made unparalleled and groundbreaking contributions to the field of cell and gene therapy for cancer.
“Without the donors, Alliance for Cancer Gene Therapy doesn’t exist,” Dr. Mackall said, later adding that “you get (a foundation like ACGT) by having a leadership with great instincts, leadership that is passionate, and leadership that has grit.”